These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6156759)

  • 21. [alpha 1-fetoprotein and Tennessee antigen in hepatocellular carcinomas and in metastatic liver cancer (author's transl)].
    Polterauer P; Müller M
    Wien Klin Wochenschr; 1982 Feb; 94(4):102-5. PubMed ID: 6177106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of immunoglobulin G in human sera binding to alphafetoprotein.
    Nakata K; Muro T; Furukawa R; Kono K; Kusumoto Y; Ishii N; Munehisa T; Koji T; Nagataki S
    Oncodev Biol Med; 1983; 4(6):C101-4. PubMed ID: 6196748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioimmunodetection of cancer with radiolabeled antibodies to alpha-fetoprotein.
    Kim EE; DeLand FH; Nelson MO; Bennett S; Simmons G; Alpert E; Goldenberg DM
    Cancer Res; 1980 Aug; 40(8 Pt 2):3008-12. PubMed ID: 6156758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioimmunodetection and autoradiographic localization of monoclonal antibody against human hepatocellular carcinoma in xenografts.
    Ji YY; Liu YF; Chen ZN
    Cancer; 1992 Apr; 69(8):2055-9. PubMed ID: 1311979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status.
    Volkmann M; Müller M; Hofmann WJ; Meyer M; Hagelstein J; Räth U; Kommerell B; Zentgraf H; Galle PR
    Hepatology; 1993 Sep; 18(3):559-65. PubMed ID: 7689531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibody-targeted radio-chemotherapy of human primary liver cancer with radio-iodinated AFP monoclonal antibodies conjugated with mitomycin C: a preliminary clinical observation].
    Li Z; Wu Y; Zhou D
    Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):368-71. PubMed ID: 9387278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
    Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antigen showing alternative to alpha-fetoprotein expression in rat hepatomas].
    Eraĭzer TL; Iazova AK; Poltoranina VS; Kuprina NI; Shipova LIa; Lunkina AB; Lazarevich NL; Abelev GI
    Biull Eksp Biol Med; 1996 Nov; 122(11):536-40. PubMed ID: 8998346
    [No Abstract]   [Full Text] [Related]  

  • 29. [Biodistribution of monoclonal antibody and Fab fragment and antitumor effect of their conjugates on hepatoma xenografts].
    Li J; Zhen Y; Yang Z
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Oct; 16(5):328-33. PubMed ID: 7720121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Status and prospect of antibody-directed targeting treatment for hepatocellular carcinoma].
    Yang DH
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):380-1. PubMed ID: 15918978
    [No Abstract]   [Full Text] [Related]  

  • 31. Is there a role for immunotherapy in hepatocellular carcinoma?
    Zerbini A; Pilli M; Ferrari C; Missale G
    Dig Liver Dis; 2006 Apr; 38(4):221-5. PubMed ID: 16461021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of antibody to rat alpha-fetoprotein (AFP) on protein and DNA synthesis of rat ascites hepatoma AH66 cells].
    Ohkawa K; Tsukada Y; Hirai H
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):227-34. PubMed ID: 6198967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental study on immune serum therapy of cancer].
    Tsukada Y
    Gan To Kagaku Ryoho; 1988 May; 15(5):1671-6. PubMed ID: 2453162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity.
    Wang X; Wang Q
    Can J Gastroenterol Hepatol; 2018; 2018():9049252. PubMed ID: 29805966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiolabeled antibody therapy.
    Bucholtz JD
    Semin Oncol Nurs; 1987 Feb; 3(1):67-73. PubMed ID: 3031793
    [No Abstract]   [Full Text] [Related]  

  • 36. [131I-labelled tumor-specific antibodies: a trials to concentrate radioisotoopes specifically in the tumor. II. The binding of 131I-labelled anti-human alpha-fetoprotein antibody to the cultured human hepatoma cells].
    Makidono R; Watanabe K; Terashima H; Matsuura K; Nomoto K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1973 May; 33(5):418-20. PubMed ID: 4359483
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-tumor effects of immunotherapeutic peptide on the treatment of hepatocellular carcinoma with HBc carrier.
    Kong J; Diao Z; Deng X; Zhong H; Yao W; Hu X
    Oncol Rep; 2007 Jul; 18(1):279-85. PubMed ID: 17549380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rabbit antibodies to nucleoli of Novikoff hepatoma and normal liver of the rat.
    Busch RK; Daskal I; Spohn WH; Kellermayer M; Busch H
    Cancer Res; 1974 Sep; 34(9):2362-7. PubMed ID: 4367290
    [No Abstract]   [Full Text] [Related]  

  • 39. Immune therapy for liver cancer.
    Harrington M
    Lab Anim (NY); 2014 Aug; 43(8):257. PubMed ID: 25050714
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of anti-ferritin antibody in the diagnosis and treatment of hepatocellular carcinoma].
    Liu KD
    Zhonghua Yi Xue Za Zhi; 1987 Nov; 67(11):621. PubMed ID: 2834028
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.